Promoting the Quality of Medicines Program Final Report
Between 2009 and 2020, the U.S. Agency for International Development and the U.S. Pharmacopeia partnered through the Promoting the Quality of Medicines (PQM) program to improve quality assurance systems to increase access to quality-assured priority medical products and decrease the prevalence of substandard or falsified medicines in low- and middle-income countries. The PQM program strengthened more than 90 quality control laboratories in 33 countries and built the capacity of 45 manufacturers in 12 countries to produce quality essential medicines. Read the program’s final report to learn more about the progress made worldwide.
- PQM Experience in Kazakhstan Included in WHO Publication on Good Practices for Accelerating Efforts to End TB (03/2019)
- Uzbekistan’s Medicines Quality Control Laboratory Well on the Path to Achieving International Standards (11/2018)
- Nigeria’s National Institute for Pharmaceutical Research and Development Attains International Accreditation (08/2018)
- Readying Health Systems in Central Asia and Eastern Europe for a New Medicine in the Fight Against MDR-TB (07/2018)
- PQM Supports a Regional Approach to Medicines Quality Surveillance in the Horn of Africa (07/2018)
- PQM and Protecting Medicines Quality in Africa:3rd Biennial Scientific Conference on Medical Products Regulation (02/2018)
- Ensuring the Quality of Priority Medicines: Workshop for National Medicines Regulatory Authorities and Manufacturers of Anti-Tuberculosis and Neglected Tropical Disease Products (07/2017)
- USP and WHO Conclude Joint Training for Regulators in East African Community (07/2017)
- PQM’s FY 2016 Annual Performance Report Now Available (01/2017)
To learn more about the PQM program’s activities worldwide, read our annual performance report for FY 2016.
- FDA Ghana Achieves International Reaccreditation (05/2016)
- PQM Helps Bring Relief to Patients Who Suffer from Parasitic Worm Infections (04/2016)
- PQM Partners with Liberia’s Regulatory Agency to Monitor Medicines Quality (03/2016)
- Study Examines Effectiveness of Novel CD3+ Screening Technology to Detect Poor Quality Medicines (02/25/2016)